Introduction {#s1}
============

Reactive oxygen species (ROS) are by-products of aerobic metabolism, and respiration is considered to be the major intracellular source of ROS production in bacteria (Brynildsen et al., [@B10]; Imlay, [@B25]). Methionine residues in proteins are particularly susceptible to oxidation by ROS (Vogt, [@B60]; Stadtman et al., [@B54]), resulting in methionine-*S*-sulfoxides \[Met-S-(O)\] and methionine-*R*-sulfoxides \[Met-R-(O); (Luo and Levine, [@B35]; Kim et al., [@B28])\]. Oxidized methionine can be repaired by the antioxidant enzymes, Met-S-(O) reductase (MsrA) and Met-R-(O) reductase (MsrB). Both Msr share a common catalytic mechanism to reduce Met(O) back to Met. This catalytic mechanism leads to the formation of an intramolecular disulfide bond in the Msr and involves thioredoxin (Trx), thioredoxin reductase, and NADPH (Weissbach et al., [@B61]). It has been shown that MsrA reduces both oxidized proteins and low molecular weight Met(O)-containing compounds with a similar catalytic efficiency, whereas MsrB is specialized for the reduction of Met(O) in proteins. Interestingly, both Msr types preferentially repair unfolded proteins (Tarrago et al., [@B56]). The genes encoding MsrA and MsrB have been identified in most living organisms. Four different types of organization have been reported for *msrA* and *msrB*: (i) *msrA* and *msrB* genes are two separate transcription units, (ii) *msrA* and *msrB* cistrons are organized as an operon, (iii) *msr*A and *msrB* cistrons form a single open reading frame (ORF) to produce a two domain protein, and (iv) *trx, msrA*, and *msrB* cistrons form a single ORF to produce a three domain protein (Drazic and Winter, [@B17]).

Several studies have revealed the importance of Met oxidation and Msrs, especially regarding oxidative stress resistance and metabolism under stress conditions. In addition, Msrs have also been reported to be important virulence factors in pathogens by modulating a range of properties such as adherence (Wizemann et al., [@B63]; Giomarelli et al., [@B22]), motility (Hassouni et al., [@B24]), biofilm formation (Beloin et al., [@B9]), and *in vivo* survival (Alamuri and Maier, [@B2]). However, the importance of Met oxidation and Msr in the secretion of virulence factors under normal physiological conditions is largely unknown in pathogens, and in particular in *Bacillus cereus*.

*B. cereus* is a Gram-positive, motile human pathogen that is well-equipped to survive in various environments such as those encountered in soil, food and the human gastrointestinal tract (Stenfors Arnesen et al., [@B55]). These bacteria can grow in the presence or absence of oxygen (Rosenfeld et al., [@B49]; Duport et al., [@B21]). In the human intestine, *B. cereus* encounters oxic conditions in zones adjacent to the mucosal surface (Marteyn et al., [@B39]) and anoxic conditions in the intestinal lumen (Moriarty-Craige and Jones, [@B41]). In the presence of oxygen, *B. cereus* grows by means of aerobic respiration and secretes a large number of proteins into the extracellular compartment. These secreted proteins, and all the released proteins found in the pathogen\'s surrounding environment, constitute the *B. cereus* exoproteome (Clair et al., [@B13], [@B12]; Laouami et al., [@B31]). We previously reported that the *B. cereus* exoproteome contained protein-bound Met(O) and that the accumulation of protein-bound Met(O) decreased significantly during aerobic respiratory growth, to reach its minimal value at the stationary phase (Madeira et al., [@B36]). Insofar as there is no ROS source and no Msr to reduce Met(O) back to Met in the extracellular milieu, we assumed that the time dynamic of protein-bound Met(O) in the *B. cereus* exoproteome could reflect the growth phase-dependent activity of an intracellular Msr. Here, we show that *B. cereus* encodes a functional MsrAB methionine sulfoxide reductase that is responsible for the decrease of the Met(O) content of the *B. cereus* exoproteome during aerobic respiratory growth. In addition, our results provide evidence that Met residues in exoproteins, especially enterotoxins, and their recycling by MsrAB, can serve as an antioxidant system that could trap ROS and maintain redox homeostasis in cells.

Materials and methods {#s2}
=====================

Construction of a Δ*msrAB* mutant and its complementation
---------------------------------------------------------

Mutant construction was performed according to the procedure developed by Arnaud et al. ([@B7]). The *msrAB* ORF was interrupted by insertion of a non-polar spectinomycin resistance expression cassette, spc (Murphy, [@B43]) as follows. A DNA fragment of 1,413 bp encompassing the *msrAB* ORF was amplified from *B. cereus* genomic DNA by PCR with primers 5′-gaattcTCATGCCTTGAAAGTTACGG-3′ and 5′-agatctTTGGCGTAACGGTAATTGGT-3′, which contained *EcoR*I and *Bgl*II restriction sites, respectively. The amplified DNA fragment was cloned into pCRXL-TOPO (Invitrogen). The resulting pCRXL*msrAB* plasmid was digested with *Stu*I. A 1.5 kb *Sma*I fragment containing spc was purified from pDIA (Laouami et al., [@B32]) and ligated into *Stu*I-digested pCRXL*msrAB*. The resulting plasmid, pCRXL*msrAB*Δspc, was digested with *EcoR*I plus *Bgl*II. The *msrAB*Δspc fragment was then subcloned into *EcoR*I/*Bgl*II sites of pMAD (Arnaud et al., [@B7]). This construct was used for *B. cereus* transformation (Omer et al., [@B44]). For complementation of the Δ*msrAB* mutant with wild-type *msrAB* gene, the 1,413 bp *EcoR*I-*Bgl*II fragment was cloned into pHT304 (Arantes and Lereclus, [@B6]). *MsrAB* is under the control of its own promoter into pHT304-*msrAB*.

*B. cereus* strains and growth conditions
-----------------------------------------

Wild-type *B. cereus* ATCC 14579 without its pBClin15 plasmid (Madeira et al., [@B37],[@B38]), its Δ*msrAB* mutant and Δ*msrAB*/pHT304*msrAB* complemented strains were grown in MOD medium supplemented with 30 mM glucose as the carbon source, as previously described (Madeira et al., [@B38]). The inoculum was a sample of exponential subculture harvested by centrifugation, washed and diluted in fresh medium to obtain an initial optical density at 600 nm of 0.02. Three independent batch cultures (biological replicates) were carried out at 37°C for each strain.

Analytical procedures and growth parameters
-------------------------------------------

*B. cereus* growth was monitored spectrophotometrically at 600 nm. The specific growth rate (μ) was determined using the modified Gompertz equation (Zwietering et al., [@B64]). Cells and filtered culture supernatants were harvested at the indicated growth stage as previously described (Madeira et al., [@B36], [@B38]). Exoproteins were immediately precipitated from the culture supernatant using trichloroacetic acid (TCA), as previously described, and stored at 4°C until analysis. The concentrations of substrate, and by-products in the filtered culture supernatants were determined with Enzytec Fluid kits purchased from R-Biofarm, as described by the manufacturer. Exoprotein concentration was determined by the Bradford protein assay (Pierce).

Protein sample preparation, trypsin in-gel proteolysis, and nano-LC-MS/MS analysis
----------------------------------------------------------------------------------

Protein extraction and subsequent digestion were performed as previously described (Madeira et al., [@B36]). Extracellular and intracellular proteins from the 27 samples (biological triplicates from the three time conditions for the wild-type, Δ*msrAB* and Δ*msrAB*/pHT304-*msrAB* strains) were resolved on NuPAGE® 4--12% Bis-Tris gels (Invitrogen) that were run for a short (about 3 mm) electrophoretic migration using NuPAGE MES supplemented with NPAGE antioxidant as the running buffer (Hartmann and Armengaud, [@B23]). This avoids artefactual protein oxidation. For each of the 54 protein samples, the whole protein content was extracted as a single polyacrylamide band. The bands were subjected to proteolysis with sequencing grade trypsin (Roche) following the ProteaseMAX protocol (Promega), as previously described (De Groot et al., [@B16]; Clair et al., [@B13]). NanoLC-MS/MS experiments were performed using an LTQ-Orbitrap XL hybrid mass spectrometer (ThermoFisher) coupled to an Ultimate 3000 nRSLC system (Dionex, ThermoFisher; Dedieu et al., [@B15]; Madeira et al., [@B36]).

Peptide and protein identification from MS/MS datasets
------------------------------------------------------

MS/MS spectra were searched against an in-house polypeptide sequence database corresponding to an improved annotation of the *B. cereus* ATCC 14,579 genome (Madeira et al., [@B37]). The MASCOT Daemon search engine (version 2.3.02; Matrix Science) was used to search tryptic peptides as previously described (Dupierris et al., [@B19]; Madeira et al., [@B37]). The mass spectrometry proteomics data have been deposited in the ProteomeXchange Consortium (<http://proteomecentral.proteomexchange.org>) via the PRIDE partner repository (<http://www.ebi.ac.uk/pride>) with the dataset identifiers, PXD006169 and 10.6019/PXD006169 (exoproteome) and, PXD006205 and 10.6019/PXD006205 (cellular proteome).

Label-free comparative proteomics
---------------------------------

Analyses of changes of peptides and proteins in terms of abundance were achieved by comparing the spectral counts of proteins after voom transformation of abundance values using the R package LIMMA (Ritchie et al., [@B47]), as previously described (Madeira et al., [@B38]). Data were normalized using the trimmed mean of *M*-values (TMM), implemented in the R package edgeR (Robinson et al., [@B48]). For quantitative comparisons, data were filtered to have two valid values in at least two biological replicates. Since we were specifically interested in the comparison between wild-type, Δ*msrAB* mutant and the complemented strain Δ*msrAB*/pHT-*msrAB*, we conducted differential analysis between WT and Δ*msrAB*, as well as Δ*msrAB* and Δ*msrAB*/pHT-*msrAB*, and WT and Δ*msrAB*/pHT-*msrAB*, individually. Differential protein and peptide abundances between WT and Δ*msrAB*, between Δ*msrAB* and Δ*msrAB*/pHT-*msrAB*, and between WT and Δ*msrAB*/pHT-*msrAB* were considered significant at stringent *p*-values (≤0.01). The results are presented as log~2~ fold-changes.

Real-time RT-PCR and 5′RACE assays
----------------------------------

Total RNA was prepared as described previously (Omer et al., [@B44]). Real-time RT-PCR was performed using the iScript™ One-Step RT-PCR kit with SYBR® Green following the manufacturer\'s protocol (Biorad). The *msrAB*-specific primer pair used in this study was: 5′-TTCTGGTACACAGGTGGTC-3′ and 5′-AAAGCGTCCACTCTGCTCAA-3′. Gene expression was normalized by the ΔΔCT analysis. The 16s rDNA was used as the reference gene in the calculations. The 16S rDNA-specific primer pair was 5′-TCCAACTGATGGCGGAC-3′ and 5′-TCACGCCCAGATTCTTTTTGC-3′. Rapid amplification of 5′ complementary cDNA ends (5′RACE) was performed using the 5′/3′ RACE kit (Sigma). The *msrAB* specific primers SP1, SP2 and SP3 were: 5′-ATGTCCCGTCGTTTCTGAAC-3, 5′-TCAAATGGCGAAACCATACA-3′ and 5′-CCATACACCAGAAGCACCCT-3′, repectively.

Protease activity assay
-----------------------

Sigma\'s non-specific protease activity assay was used to determine the protease activity of filtered culture supernatant. In this assay, casein acts as a substrate. Tyrosine, which is released on hydrolysis of casein by proteases, is able to react with Folin-Ciocalteu\'s reagent to produce a blue chromophore. The quantity of this chromophore was measured by means of its absorbance value by spectrophotometry. Absorbance values generated by the activity of the protease were compared to a standard curve, which was generated on the basis of known quantities of tyrosine. From the standard curve, the activity of protease samples was determined in units, corresponding to the amount in micromoles of tyrosine equivalents released from casein per minute. Experiments were performed twice for each of the 27 filtered culture supernatants. Statistical differences were evaluated by the Student\'s *t*-test.

Long-term survival
------------------

The survival of WT, Δ*msrAB* mutant, and complemented Δ*msrAB* mutant were determined as follows. After 24 h incubation at 37°C on glucose containing MOD medium, cultures were transferred to 4°C. An aliquot of each culture was collected before and after 1, 2, 3, 4, and 5 days of exposure to 4°C. Viable cells were determined by serial dilution of cultures in PBS, plating on LB agar, and incubation overnight (37°C). Experiments were performed in triplicate. Statistical differences were evaluated by the Student\'s *t*-test.

Results {#s3}
=======

*msrAB* expression is growth phase dependent
--------------------------------------------

Genome analyses of *B. cereus* ATCC 14579 identified an ORF (BC_5436) encoding a cytoplasmic protein annotated as MsrAB (NP_835097). This predicted cytoplasmic protein is composed of 321 amino acids and has a molecular weight of 36,938 Da. MsrAB and its gene *msrAB* are strongly conserved in members of the *B. cereus* group (data not shown). We mapped the transcriptional start site of *msrAB* by 5′RACE. The transcriptional start site (G) was located 23 nt upstream of the translational start codon and was preceded by a region similar to σE consensus-35 (TAATATG) and -10 (CATACTG) boxes separated by 13 nt. Furthermore, *msrAB* appeared to be followed by an inverted repeat (ΔG° = 23.6 kcal/mol) that may a transcriptional terminator (Figure [S1](#SM6){ref-type="supplementary-material"}). This indicates that *msrAB* may be transcribed as a single unit. To determine whether there is any regulation of *msrAB*, mRNA levels were measured at early exponential (EE), late exponential (LE) and stationary (S) growth phases. Figure [1](#F1){ref-type="fig"} shows that there was about a 30-fold increase in *msrAB* expression for cells harvested at the S growth phase compared with the EE growth phase. *B. cereus msrAB* expression was thus maximal over the stationary phase. Similar stationary phase-induced expression of *msr* genes has been documented in several bacteria (Moskovitz et al., [@B42]; Vattanaviboon et al., [@B57]; Alamuri and Maier, [@B3]; Singh and Singh, [@B53]).

![Growth phase-dependent changes of *msrAB* transcript levels in wild-type (blue) and complemented Δ*msrAB*/pHT304*msrAB* (green) strains. Fold changes refer to the levels observed in early exponential (EE) phase cultures of the WT strains. Significant differences are indicated with one (*p* \< 0.05) asterisks. LE, Late exponential growth phase; S, Stationary growth phase.](fmicb-08-01342-g0001){#F1}

MsrAB contributes to *B. cereus* respiratory metabolism
-------------------------------------------------------

To investigate the role of MsrAB in *B. cereus*, we constructed a non-polar Δ*msrAB* mutant and a Δ*msrAB*-complemented strain using a multicopy pHT304-based plasmid (Arantes and Lereclus, [@B6]). Expression of *msrAB* in the complemented strain was under the control of its own promoter. We did not detect *msrAB* mRNA by RT-PCR in the mutant, proving that the genomic disruption of the gene generated an *msrAB*-null mutant. Figure [1](#F1){ref-type="fig"} shows that *msrAB* was overexpressed in the strain Δ*msrAB*/pHT304*msrAB* at the EE and LE growth phases. Therefore, *msrAB* expression level was not restored by complementation.

The growth characteristics of the three strains, Δ*msrAB*, Δ*msrAB*/pHT304*msrAB*, and the parental wild-type strain (WT), were determined under pH-regulated aerobic respiratory conditions in synthetic MOD medium. Figure [2A](#F2){ref-type="fig"} shows that the lag phase was 2.5-fold lower in the Δ*msrAB* strain (0.7 ± 0.1 h^−1^) than in the Δ*msrAB*/pHT304*msrAB* (1.8 ± 0.9 h^−1^) and WT (1.9 ± 0.2 h^−1^) strains. Exponential growth kinetics were similar in the three strains for the first 6 h. After this initial growth time, WT and Δ*msrAB* cultures entered stationary phase. In contrast, Δ*msrAB*/pHT304*msrAB* continued to grow and reached the stationary growth phase at a higher final biomass (2.6 ± 0.1 g.L^−1^) than Δ*msrAB* (1.9 ± 0.1 g.L^−1^) and WT (1.8 ± 0.2 g.L^−1^). The viabilities of Δ*msrAB* and Δ*msrAB*/pHT304*msrAB* cells, harvested at S growth phase, were similar to the viability of WT after 2 days but declined by more than 100-fold after 5 days of storage at 4°C (Figure [2B](#F2){ref-type="fig"}). This suggests that *msrAB* expression impacts the metabolic activity of *B. cereus* cells at the end of growth (Chubukov and Sauer, [@B11]). Figure [2C](#F2){ref-type="fig"} shows that the Δ*msrAB* and Δ*msrAB*/pHT304*msrAB* strains consumed higher amounts of glucose than WT at the beginning of exponential growth. The Δ*msrAB*/pHT304*msrAB* culture could be distinguished from the Δ*msrAB* culture by continued glucose consumption between the LE and S growth phases (Figure [2C](#F2){ref-type="fig"}). At the end of growth, Δ*msrAB*/pHT304*msrAB* consumed a higher level of glucose than Δ*msrAB* and WT. During aerobic respiratory growth, glucose is catabolized into CO~2~ through the TCA cycle, and acetate is excreted as a by-product of overflow metabolism (Madeira et al., [@B36]; Duport et al., [@B20]). Figure [2D](#F2){ref-type="fig"} shows that Δ*msrAB* cells, and to a lesser extent Δ*msrAB*/pHT304*msrAB* cells, excreted higher amounts of acetate than WT cells during exponential growth. Acetate accumulation stopped at the LE growth phase in the Δ*msrAB* and Δ*msrAB*/pHT304*msrAB* cultures while it continued to accumulate between the LE and S growth phases in the WT culture. Taken together, these results suggest that *msrAB* expression impacts on the metabolic activity of *B. cereus* under aerobiosis.

![Altered growth and long-term survival of Δ*msrAB* mutant cells and complemented Δ*msrAB*/pHT304*msrAB* cells. **(A)** Growth curves of WT (blue), Δ*msrAB* (red) and Δ*msrAB*/pHT304*msrAB* (green) cells in pH-regulated batch cultures under aerobiosis. **(B)** Long-term survival of WT (blue), Δ*msrAB* (red) and Δ*msrAB*/pHT304*msrAB* (green) cells after growth under aerobiosis. **(C)** Glucose consumption of WT (blue), Δ*msrAB* (red) and Δ*msrAB*/pHT304*msrAB* (green) cells. **(D)** Acetate production of WT (blue), Δ*msrAB* (red) and Δ*msrAB*/pHT304*msrAB* (green) cells. Significant differences are indicated with one (*p* \< 0.05) or two (*p* \< 0.01) asterisks.](fmicb-08-01342-g0002){#F2}

To determine whether the alteration of glucose catabolism was associated with changes in extracellular protein production, extracellular proteins were extracted from culture supernatants of the three *B. cereus* strains, harvested during the EE, LE, and S growth phases (Madeira et al., [@B36]). Figure [3A](#F3){ref-type="fig"} shows that the Δ*msrAB* culture supernatant accumulated a higher amount of exoproteins than that of WT at the LE phase. However, Δ*msrAB* supernatant had 50 and 90% fewer exoproteins in the EE and S growth phases, respectively, compared with WT. This decreased exoprotein concentration could have resulted from a higher protease activity in the Δ*msrAB* culture supernatant. To test this hypothesis, we quantified the protease activity of the Δ*msrAB*, Δ*msrAB*/pHT304*msrAB* and WT culture supernatants against casein. Figure [3B](#F3){ref-type="fig"} shows that the Δ*msrAB* culture supernatant sustained a higher protease activity than WT, markedly in the EE and S growth phases. These changes in protease activity were only partially rescued in Δ*msrAB*/pHT304*msrAB*. However, unlike Δ*msrAB*/pHT304*msrAB*, there was no correlation between the protease activity and the amount of exoproteins in Δ*msrAB* at LE phase (Figure [3A](#F3){ref-type="fig"}). This indicates that changes in *msrAB* expression could be selective for certain extracellular proteases.

![Exoproteome concentration and protease assay. Concentrations **(A)** and casein proteolytic activity **(B)** are indicated for total extracellular proteins of WT (blue), Δ*msrAB* (red) and Δ*msrAB*/pHT304*msrAB* (green) cells. Error bars represent the standard deviation from two independent measures for each biological triplicate. Significant differences (*p* \< 0.01) between WT, Δ*msrAB* and Δ*msrAB*/pHT304*msrAB* strains are indicated with two asterisks.](fmicb-08-01342-g0003){#F3}

MsrAB modulates the proteome profile of *B. cereus*
---------------------------------------------------

To determine if altered metabolism in Δ*msrAB* and Δ*msrAB*/pHT304*msrAB* was associated with cellular and exoproteome profile changes, we quantified protein abundance level differences between Δ*msrAB*, Δ*msrAB*/pHT304*msrAB*, and WT cells in the EE, LE and S growth phases. Exoproteome and cellular proteome samples were prepared from supernatant cultures and whole-cell lysates, respectively. A total of 200,746 and 71,676 MS/MS spectra were recorded from cellular proteome and exoproteome samples, respectively. A total of 922 proteins were identified in the cellular proteome (Table [S1](#SM1){ref-type="supplementary-material"}) and 371 proteins were identified in the exoproteome (Table [S2](#SM2){ref-type="supplementary-material"}), based on the confident detection of at least two different peptides. A two-sample *t*-test was then conducted separately between WT and Δ*msrAB*, and between Δ*msrAB* and Δ*msrAB*/pHT304*msrAB*. All proteins with a *p* ≤ 0.01 and at least a 2-fold change (log~2~ fold-change ≥ 1) were considered to be differentially modulated in terms of abundance. A total of 64 and 78 proteins were found to vary in abundance in Δ*msrAB* compared with WT in the cellular proteome and exoproteome fractions, respectively. The majority (80%) of these proteins were not rescued in Δ*msrAB*/pHT304*msrAB* (data not shown). The Venn diagrams presented in Figure [4](#F4){ref-type="fig"} show the growth phase distribution of the identified proteins. Less than 2% of proteins showed abundance level changes in all three growth stages, indicating that *msrAB* modulates *B. cereus* cellular and exoproteome mainly in a growth phase-dependent manner. The impact of *msrAB* disruption appeared to be more important at the LE and S than the EE growth phase in the cellular proteome (Figure [4A](#F4){ref-type="fig"}), according to its expression (Figure [1](#F1){ref-type="fig"}).

![Distribution of proteins showing abundance level changes (*p* \< 0.05) between wild-type and Δ*msrAB* mutant strains. Venn diagrams showing the number of regulated intracellular proteins **(A)** and exoproteins **(B)** in the Δ*msrAB* mutant in the early exponential (EE), late exponential (LE) and stationary (S) growth phases.](fmicb-08-01342-g0004){#F4}

### Cellular proteins

Table [1](#T1){ref-type="table"} lists the identities and putative functions of the cellular proteins differentially produced in Δ*msrAB* compared with WT. In the EE phase, three proteins impacted by *msrAB* disruption were classified as carbohydrate metabolism enzymes. The glycolytic enzyme, Tpi (triose phosphate isomerase), and the two TCA enzymes, Mqo (malate:quinone oxidoreductase) and FumB (fumarate hydratase), were less abundant in Δ*msrAB* than WT. Tpi catalyzes the interconversion of dihydroacetone phosphate (DHAP) and glyceraldehyde-3-phosphate to prevent DHAP accumulation. It has been shown that a reduction of Tpi activity redirected the carbon flux from glycolysis to the pentose phosphate pathway (PPP), which provides the redox power for antioxidant systems (Ralser et al., [@B45]). FumB catalyzes the reversible hydration of fumarate to malate, and Mqo oxidizes malate to oxaloacetate and reduces quinone via a one-transfer electron reaction (Kabashima et al., [@B26]). By decreasing FumB and Mqo levels, Δ*msrAB* cells can thus decrease TCA activity, and consequently respiratory chain activity and ROS production. The reduction of respiratory chain capacity could be compensated by increasing glycolytic flux and increasing overflow metabolism (acetate excretion), as observed in Figure [2](#F2){ref-type="fig"}. Only one stress response-related protein (USP) was shown to be differentially produced in Δ*msrAB* at EE phase. As recently reported, USP may function as a protein regulator of downstream effectors of nucleotide-binding protein cycling. This activity depends on the energy status (ATP level) of the cells (Banerjee et al., [@B8]). A decrease in the UPS abundance level in Δ*msrAB* could thus reflect a change in ATP availability and/or demand at EE phase. Δ*msrAB* also sustained a higher level of RibD whatever the growth phase. The gene encoding RibD belongs to the putative operon *ribDEAH*, which encodes RibD, a pyrimidine deaminase/reductase, RibE, the α-subunit of riboflavin synthase, RibA, the GTP cyclohydrolase/3,4-dihydroxy 2-butanone 4-phosphate (3,4-DHBP) synthase, and RibH, the β-subunit of riboflavin (RibH). These enzymes form a pathway that produces one riboflavin molecule from GTP and ribulose-5-phosphate (Vitreschak et al., [@B59]). RibA and RibH were more highly produced in Δ*msrAB* than in WT at LE growth phase and RibE was more highly produced at S growth phase. Together these results suggest the increased production in Δ*msrAB* of riboflavin, which is known to be an element of antioxidant defense (Abbas and Sibirny, [@B1]). One stress-related protein, named AcpD (annotated as an azoreductase), which was not detected in WT cells (Table [S1](#SM1){ref-type="supplementary-material"}), was significantly induced at both LE and S growth phases in Δ*msrAB* cells. AcpD is a putative FMN-NAD(P)H-dependent quinone oxidoreductase that catalyzes the two-electron reduction of quinones to quinols. This protein could play an important role in managing oxidative stress in the absence of *msrAB* by maintaining the reduced antioxidant form of quinone (Ross et al., [@B50]; Ryan et al., [@B51]). Several proteins related to the biosynthesis of amino acids were upregulated at the LE and S phases. This suggests that an increase in the intracellular content of these amino acids may be part of the adaptive response to the lack of MsrAB.

###### 

Cellular proteins with significant abundance level changes (\|log~2~\|fold-change \> 1, *p* \< 0.01) in Δ*msrAB* compared with WT.

  **Functional class**                    **NP no**.      **Gene no**.           **Protein name**   **Protein description**                                      **Log~2~ fold-change**           
  --------------------------------------- --------------- ---------------------- ------------------ ------------------------------------------------------------ ------------------------ ------- -------
  Carbohydrate metabolism                 **NA**          **[BC5137](BC5137)**   **Tpi**            **Triosephosphate isomerase**                                −1.50                            
                                          NP_834982       [BC5320](BC5320)       Ccr                PTS system, glucose-specific IIA component                                            1.82    
                                          NP_834343       [BC4637](BC4637)       Ack                acetate kinase                                                                                1.09
                                          NP_832706       [BC2959](BC2959)       Mqo                Malate:quinone oxidoreductase                                −2.82                            
                                          NP_831487       [BC1712](BC1712)       FumB               Fumarate hydratase                                           −2.57                            
                                          NP_833692       [BC3973](BC3973)       PdhA               Pyruvate dehydrogenase E1 component alpha subunit                                             1.02
                                          NP_833555       [BC3834](BC3834)       SucC               Succinyl-CoA synthetase subunit beta                                                          1.05
  Enterotoxin                             NP_834610       [BC5239](BC5239)       EntA               Enterotoxin A                                                                                 −4.07
  Lipid metabolism                        **NP_830401**   **[BC0584](BC0584)**                      **Acetyltransferase**                                                                         −2.04
  Cell wall and cell surface metabolism   NP_830495       [BC0682](BC0682)       SrtA               Sortase                                                                               −3.01   
                                          NP_834255       [BC4548](BC4548)       IsdA1              Cell surface protein                                                                          −4.19
  Purine metabolism                       NP_832069       [BC2306](BC2306)       BacF               Glycine-AMP ligase                                                                    −3.94   
                                          **NP_831124**   **[BC1343](BC1343)**   **QueE**           **Organic radical activating protein**                                                        2.63
                                          **NP_831122**   **[BC1341](BC1341)**   **QueC**           **Aluminum resistance protein**                                                               3.28
  Pyrimidine metabolism                   NP_833606       [BC3886](BC3886)       CarB               Carbamoyl phosphate synthase large subunit                                            −4.35   
                                          NP_833803       [BC4085](BC4085)       Pdp                Pyrimidine-nucleoside phosphorylase                                                   2.14    
  DNA binding and repair                  NP_831634       [BC1861](BC1861)                          Helicase                                                     −3.15                            
                                          NP_831628       [BC1855](BC1855)                          Chromosome segregation ATPase                                −2.46                            
                                          NP_834171       [BC4459](BC4459)       HsdM               Type I restriction-modification system methylation subunit                            −2.51   
                                          NP_831628       [BC3769](BC3769)       MutS               DNA mismatch repair protein                                                           −2.58   
  Aminoacid metabolism                    NP_833492       [BC1546](BC1546)       Aat                Aspartate aminotransferase                                                                    1.74
                                          NP_831735       [BC1965](BC1965)       ThrC               Threonine synthase                                                                    3.41    3.13
                                          NP_831736       [BC1966](BC1966)       ThrB               Homoserine kinase                                                                     2.64    3.30
                                          NP_832070       [BC2307](BC2307)                          Glycine-AMP ligase                                                                    −3.31   
                                          NP_831552       [BC1779](BC1779)       IlvC2              Ketol-acid reductoisomerase                                                                   1.58
                                          **NP_831190**   **[BC1410](BC1410)**   **HisF**           **Imidazole glycerol phosphate synthase subunit HisF**                                2.05    
                                          **NP_831186**   **[BC1406](BC1406)**   **HisD**           **Histidinol dehydrogenase**                                                                  3.41
                                          NP_831734       [BC1964](BC1964)       Hom1               Homoserine dehydrogenase                                                              2.86    2.35
                                          **NP_830438**   **[BC4331](BC4331)**   **AroE**           **Shikimate 5-dehydrogenase**                                2.06                             
  Amino sugar metabolism                  NP_834865       [BC5201](BC5201)       MnaA               UDP-N-acetylglucosamine 2-epimerase                                                           1.59
  Translation                             **NP_831277**   **[BC1498](BC1498)**   **RrpsA**          **30S ribosomal protein S1**                                 −3.21                            
                                          **NP_830015**   **[BC0135](BC0135)**   **RpsS**           **SSU ribosomal protein**                                    2.06                             
  Motility                                NP_831407       [BC1629](BC1629)       CheC               Flagellar motor switch protein                                                        −2.38   
                                          NP_831428       [BC1651](BC1651)       FglE               Flagellar hook protein                                                                        −3.26
                                          NP_831435       [BC1658](BC1658)       FlaB               Flagellin                                                                             −2.30   
                                          NP_831415       [BC1637](BC1637)       FlgL               Flagellar hook-associated protein                                                             −3.28
                                          NP_834158       [BC4446](BC4446)       MreB               Rod shape-determining protein                                                                 1.05
  Rod shape-determining proteins          NP_834531       [BC4831](BC4831)                          ABC transporter ATP-binding protein                                                   3.67    
  Transporters                            NP_834524       [BC4824](BC4824)                          ABC transporter ATP-binding protein                                                   −2.11   
                                          NP_833512       [BC3790](BC3790)                          Nucleoside transport ATP-binding protein                                              −3.36   
                                          NP_830967       [BC1182](BC1182)       OppD               Oligopeptide transport ATP-binding protein                                            −1.78   
                                          NP_832817       [BC3071](BC3071)       CutC               copper homeostasis protein cutC                                                               3.00
                                          **NP_834331**   **[BC4625](BC4625)**   **UspA**           **Universal stress protein**                                 −3.19                            
  Stress response                         **NP_835071**   **[BC5410](BC5410)**   **AcpD**           **Azoreductase**                                                                      4.87    5.83
                                          NP_830954       [BC1168](BC1168)       ClpB               ATP-dependent chaperone                                      −2.99                            
  Chaperones                              NP_830829       [BC1043](BC1043)       PrsA1              Peptidylprolyl isomerase                                                                      1.08
                                          NP_833827       [BC4109](BC4109)       RibD               Diaminohydroxyphosphoribosylaminopyrimidine deaminase        2.78                     2.92    4.42
  Riboflavin biosynthesis                 NP_833829       [BC4111](BC4111)       RibA               Bifunctional 3,4-dihydroxy-2-butanone 4-phosphate synthase                            2.87    
                                          **NP_833828**   **[BC4110](BC4110)**   **RibE**           **Riboflavin synthase subunit alpha**                                                         2.20
                                          NP_833830       [BC4112](BC4112)       RibH               Riboflavin synthase subunit beta                                                      1.68    
                                          NP_833832       [BC4114](BC4114)       BioB               Biotin synthase                                                                               3.40
  Biotin biosynthess                      **NP_831123**   **[BC1342](BC1342)**                      **6-pyruvoyl tetrahydrobiopterin synthase**                  2.16                             
  Folate biosynthesis                     NP_833540       [BC3819](BC3819)       Dxr2               1-deoxy-D-xylulose 5-phosphate reductoisomerase              2.75                             
  Terpenoid backbone biosynthesis         NP_831099       [BC1317](BC1317)       PhaB               Acetoacetyl-CoA reductase                                    −2.53                            
  Uncategorized                           NP_829927       [BC0025](BC0025)                          Unknown                                                                               2.67    
                                          NP_832675       [BC2927](BC2927)                          Prolyl endopeptidase                                                                          4.18
                                          NP_831667       [BC1894](BC1894)                          Phage protein                                                −2.84                            
                                          NP_831673       [BC1901](BC1901)                          phage protein                                                                                 −2.43
                                          NP_834610       [BC4938](BC4938)                          NADH dehydrogenase                                                                    2.03    
                                          NP_834043       [BC0622](BC0622)                          L-threonine 3-dehydrogenase                                                                   2.14
                                          NP_830802       [BC1016](BC1016)                          Unknown                                                                               3.04    
                                          NP_834559       [BC4860](BC4860)                          Unknown                                                                                       −1.97
                                          NP_829986       [BC0105](BC0105)                          Unknown                                                                                       1.87
                                          NP_834083       [BC4371](BC4371)                          Unknown                                                                                       1.57

*Proteins showing abundance level restored in ΔmsrAB/pHT304msrAB are indicated in bold. EE, early exponential growth phase; LE, late exponential growth phase; S, stationary growth phase. NA, Not Annotated. Green and red highlights indicate increased and decreased protein levels, respectively*.

A protein was considered validated when at least two different peptides were found in the same sample. We found only one peptide assigned to MsrAB and did not validate its presence in the cellular proteome. To determine whether MsrAB is a true cellular protein, we carried out further analyses using a Q-exactive HF mass spectrometer. Five and 19 peptides assigned to MsrAB were detected in the cellular proteome of WT and Δ*msrAB*/pHT304*msrAB*, respectively, at LE and S growth phases (Figure [S1](#SM6){ref-type="supplementary-material"}) No peptide was detected in the exoproteome, proving that MsrAB is cytoplasmic.

### Exoproteome

Table [2](#T2){ref-type="table"} lists the exoproteins that were considered as differentially produced in Δ*msrAB* supernatant. The majority of the metabolism and stress/detoxification-related proteins were less abundant in Δ*msrAB* compared with WT, regardless of growth phase. These proteins were predicted to be cytosolic and, accordingly, we found that they were more abundant in the cellular proteome compared with the exoproteome (Table [S3](#SM3){ref-type="supplementary-material"}). In contrast, the majority of the cell wall/surface-associated proteins, transporters and degradative/adhesin proteins, which were predicted to be secreted proteins, were increased in Δ*msrAB* compared with WT, especially at the EE and LE growth phases. This suggests that *msrAB* deletion could favor the accumulation of some secreted exoproteins at the expense of cytosolic proteins. Interestingly, two predicted secreted foldases, PrsA1 and PsrA2, showed significant increases in their abundance levels in Δ*msrAB*, especially at LE growth phase. PrsA1 and PrsA2 have been predicted to function as peptidyl-prolyl isomerases at the bacterial membrane--cell wall interface, to assist in the folding and stability of exported proteins (Vitikainen et al., [@B58]). In addition, we noted increased abundance levels of a bacterial type I signal peptidase protein (SPase) in Δ*msrAB* compared with WT at LE phase. SPases function at the terminal step of the general secretory pathway by releasing translocated proteins from the cytoplasmic membrane at a defined cleavage site (Craney et al., [@B14]). This Spase could thus function in conjunction with PrsA proteins to sustain a higher secretion level of some proteins (Alonzo et al., [@B4]).

###### 

Exoproteins with significant abundance level changes (\|log2\|fold-change \> 1, *p* \< 0.01) in Δ*msrAB* compared with WT.

  **Functional class**                             **NP no**.      **Gene no**.           **Protein name**   **Protein description**                              **Log~2~ fold-change**           
  ------------------------------------------------ --------------- ---------------------- ------------------ ---------------------------------------------------- ------------------------ ------- -------
  Metabolism                                       NP_833767       [BC4049](BC4049)       HPr                Phosphocarrier protein HPr                                                            −2.24
  Carbohydrate                                     NP_834306       [BC4600](BC4600)       Pfk                6-phosphofructokinase                                −3.09                            
                                                   NP_833689       [BC3970](BC3970)       PdhD               Dihydrolipoamide dehydrogenase                                                −2.43   
                                                   **NA**          **[BC5138](BC5138)**   **Pgk**            **Phosphoglycerate kinase**                                                   −1.79   
                                                   NP_834571       [BC4898](BC4898)       Pgi                Glucose-6-phosphate isomerase                                                 −2.30   
                                                   NP_833346       [BC3616](BC3616)       Acn                Aconitate hydratase                                  −3.30                            
  Fatty acid and phospholipid                      NP_833485       [BC3761](BC3761)       PlcA               1-phosphatidylinositol phosphodiesterase precursor                            1.15    
  Amino acids                                      NP_830183       [BC0344](BC0344)       RocA               1-pyrroline-5-carboxylate dehydrogenase              −3.18                            
                                                   **NA**          **[BC3705](BC3705)**   **GlnA1**          **Glutamine synthetase, type I**                                              −3.45   
                                                   NP_834978       [BC5316](BC5316)       GlyA               Serine hydroxymethyltransferase                      −2.58                            
                                                   NP_831022       [BC1238](BC1238)       TrpA               Tryptophan synthase subunit alpha                    −2.21                    −2.67   
                                                   **NP_833521**   **[BC3799](BC3799)**   **Asd**            **Aspartate-semialdehyde dehydrogenase**                                      −1.53   2.30
                                                   NP_834652       [BC4981](BC4981)       DcyD               Cysteine desulfhydrase                               −1.87                            
                                                   **NP_830053**   **[BC0185](BC0185)**   **RocF**           **Arginase**                                                                  −1.57   
  Amino sugar and nucleotide sugar                 NP_830056       [BC0188](BC0188)       GlmM               Phosphoglucosamine mutase                                                             3.81
  Nucleotide                                       NP_835123       [BC5468](BC5468)       AdSS               Adenylosuccinate synthetase                          −2.53                            
  Butanoate                                        NP_831099       [BC1317](BC1317)       PhaB               Acetoacetyl-CoA reductase                            −2.56                            
  Gamma Hexachlorocyclohexane degradation          NP_834220       [BC4511](BC4511)       LppC               Acid phosphatase                                                                      −2.34
  Ubiquinone and other terpenoid-quinone           NP_832068       [BC2305](BC2305)       DhbB               Isochorismatase                                      2.45                             
  Toxins                                           NP_832699       [BC2952](BC2952)       EntB               Enterotoxin/cell-wall binding protein                2.25                             
                                                   NP_832844       [BC3101](BC3101)       HblB               Hemolysin BL binding component precursor                                      1.69    
                                                   NP_833256       [BC3523](BC3523)       HlyII              Hemolysin II                                                                  −1.78   
  Degradative enzymes & adhesins                   NP_83404223     [BC4514](BC4514)       VanY4              D-alanyl-D-alanine carboxypeptidase                  1.77                             
                                                   NP_833486       [BC3762](BC3762)       Sfp                subtilisine like serine protease                     3.14                             
                                                   **NP_830673**   **[BC0887](BC0887)**   **CnaA**           **Collagen adhesion protein**                        2.96                             3.19
                                                   NP_831437       [BC1660](BC1660)       MltB               Soluble lytic murein transglycosylase                1.65                             
                                                   NP_835018       [BC5357](BC5357)       CnaC               Collagen adhesion protein                            1.77                             
                                                   NP_835020       [BC5359](BC5359)       YwaD               Aminopeptidase Y                                                              2.13    
                                                   **NP_830419**   **[BC0602](BC0602)**   **Npr600**         **Bacillolysin**                                                              2.70    
                                                   NP_832233       [BC2473](BC2473)       Blm                Beta-lactamase                                                                2.05    
                                                   NP_831066       [BC1284](BC1284)       InhA2              Immune inhibitor A precursor                                                          −4.17
                                                   NP_831063       [BC1281](BC1281)       CalY               Cell envelope-bound metalloprotease (camelysin)                                       −2.85
                                                   NP_830483       [BC0670](BC0670)       PlcB               Phospholipase C                                                                       −2.42
  Motility                                         NP_831428       [BC1651](BC1651)       FglE               Flagellar hook protein                               2.63                             
                                                   **NP_831414**   **[BC1636](BC1636)**   **FlgK**           **Flagellar hook-associated protein**                2.66                     −3.63   
                                                   NP_831435       [BC1658](BC1658)       FlaB               Flagellin                                                                     −3.70   
                                                   NP_831415       [BC1637](BC1637)       FlgL               Flagellar hook-associated protein                                                     −4.14
                                                   NP_831421       [BC1643](BC1643)       FliE               Flagellar hook-basal body protein                                                     −2.72
  Cell wall and cell surface associated proteins   NA              [BC3763](BC3763)                          Cell wall hydrolase                                  3.31                             
                                                   NP_831197       [BC1417](BC1417)       YvgJ3              phosphoglycerol transferase                          2.61                             
                                                   NP_831682       [BC1911](BC1911)       Ami                N-acetylmuramoyl-L-alanine amidase                   −2.73                            
                                                   NP_830492       [BC0679](BC0679)       Smc                Cell wall-binding protein                            1.12                             
                                                   NP_832677       [BC2929](BC2929)       PgdA               Peptidoglycan N-acetylglucosamine deacetylase                                 2.67    
                                                   NP_831846       [BC2078](BC2078)                          Hypothetical Membrane Spanning Protein                                                −3.07
                                                   NP_832595       [BC2846](BC2846)       DltD               Protein dltD precursor                                                                −2.25
                                                   NP_833426       [BC3698](BC3698)       CwpC               Cell wall endopeptidase                                                               2.34
                                                   NP_833984       [BC4270](BC4270)                          Penicillin-binding protein                           3.48                     1.94    
                                                   NP_833266       [BC3533](BC3533)       VanW               Vancomycin B-type resistance protein vanW            1.67                             
  Protein export                                   NP_832816       [BC3070](BC3070)       SipA               Signal peptidase I                                                            2.04    
  Transport                                        NP_831789       [BC2021](BC2021)       ZnuA               High-affinity zinc uptake system protein             1.48                             
                                                   NP_834656       [BC4985](BC4985)                          ABC transporter substrate-binding protein                                             −3.93
                                                   NP_830083       [BC0215](BC0215)       OppA2              Oligopeptide-binding protein oppA                                                     −2.53
                                                   NP_830606       [BC0816](BC0816)                          Periplasmic component of efflux system                                        3.09    2.50
                                                   NA              [BC1596](BC1596)                          Permease                                             3.60                     2.54    
  Stress/detoxification                            NP_831779       [BC2011](BC2011)       Dps1               Non-specific DNA-binding protein                     −2.31                    −2.32   
                                                   **NP_834714**   **[BC5044](BC5044)**   **Dps2**           **Non-specific DNA-binding protein**                                          −3.47   
                                                   **NP_833272**   **[BC3539](BC3539)**   **CspB**           **Cold shock protein**                                                        −5.13   −3.92
                                                   **NP_830215**   **[BC0376](BC0376)**   **AhpF**           **Alkyl hydroperoxide reductase subunit F**                                   −1.99   
  Protein folding                                  NP_830947       [BC1161](BC1161)       PrsA2              Peptidylprolyl isomerase                                                      2.80    
                                                   NP_830829       [BC1043](BC1043)       PrsA1              Peptidylprolyl isomerase                                                      2.57    
                                                   **NP_834192**   **[BC4480](BC4480)**   **Tig**            **Trigger factor**                                                                    −2.14
  Translation                                      NP_830029       [BC0149](BC0149)       RpmD               50S ribosomal protein L30                            1.30                             
                                                   NP_833528       [BC3806](BC3806)       RpsO               30S ribosomal protein S15                                                             −2.38
                                                   NP_830008       [BC0128](BC0128)       FusA               Elongation factor G                                                           −2.59   
                                                   NP_830009       [BC0129](BC0129)       Tuf                Elongation factor Tu                                                          −2.79   2.95
  Transcriptional regulators                       NP_830591       [BC0801](BC0801)       LytR2              LytR family transcriptional regulator                1.98                             
                                                   NP_834928       [BC5265](BC5265)       LytR1              LytR family transcriptional regulator                2.88                             
                                                   NP_831739       [BC1669](BC1669)       LytR3              LytR family transcriptional regulator                                         3.42    2.73
  Cell division                                    NP_829962       [BC0065](BC0065)                          Cell division protein DIVIC                                                   3.39    
  Uncategorized                                    NP_831643       [BC1870](BC1870)                          Phage protein                                        1.30                             
                                                   NP_831665       [BC1892](BC1892)                          Phage protein                                                                 −1.58   
                                                   NP_831667       [BC1894](BC1894)                          Phage protein                                                                 −1.89   −1.70
                                                   NP_831675       [BC1903](BC1903)                          Phage protein                                                                         −2.16
                                                   NP_832991       [BC3251](BC3251)                          Unknown                                                                       −2.71   
                                                   NP_835021       [BC5360](BC5360)                          Unknown                                                                       2.05    
                                                   NP_830068       [BC0200](BC0200)                          Unknown                                                                       1.64    
                                                   NP_832874       [BC3133](BC3133)                          Unknown                                                                               −1.86
                                                   NP_833260       [BC3527](BC3527)                          Unknown                                                                       1.75    

*Exoproteins with abundance level restored in ΔmsrAB/pHT304msrAB are indicated in bold. EE, early exponential growth phase; LE, late exponential growth phase; S, stationary growth phase. NA, Not Annotated. Green and red highlights indicate increased and decreased protein levels, respectively*.

Several proteins classified as degradative enzymes showed higher abundance levels in Δ*msrAB* compared with WT (Table [2](#T2){ref-type="table"}) and could contribute to the high protease activity of the Δ*msrAB* extracellular milieu (Figure [3B](#F3){ref-type="fig"}). Interestingly, we showed that the abundance level of Npr600, a predicted bacillolysin, was restored in Δ*msrAB*/pHT304*msrAB* at LE phase. Npr600 could thus be a major contributor to the protease activity of Δ*msrAB* at LE phase (Altincicek et al., [@B5]).

*msrAB* regulates the dynamic of the Met(O) content of the *B. cereus* proteome
-------------------------------------------------------------------------------

We identified peptides with oxidized Met in Δ*msrAB*, Δ*msrAB*/pHT304*msrAB*, and WT, in both the cellular proteome and the exoproteome at EE, LE, and S growth phases, as previously described (Madeira et al., [@B36]). The Met(O) content of both the cellular proteome and the exoproteome was estimated by comparing the number of Met(O) to the total number of Met residues identified in each of the three biological samples obtained for each growth phase in each of the three strains (Tables [S4](#SM4){ref-type="supplementary-material"}, [S5](#SM5){ref-type="supplementary-material"}). Figure [5](#F5){ref-type="fig"} shows that the Met(O) content of WT and Δ*msrAB*/pHT304*msrAB* decreased similarly in the cellular proteome (Figure [5A](#F5){ref-type="fig"}) and exoproteome (Figure [5B](#F5){ref-type="fig"}) during growth. The Met(O) content of the Δ*msrAB* intracellular proteome also decreased during exponential growth and was lower than the Met(O) content of WT at LE phase and higher at S growth phase. More importantly, the Met(O) content of the Δ*msrAB* exoproteome remained constant during growth and accounted for 38 ± 3% of total Met residues. Taken together, these results indicate that MsrAB regulates the dynamic of the Met(O) content of the proteome, especially at the exoproteome level.

![Dynamics of Met(O) content in Δ*msrAB* mutant cells and complemented Δ*msrAB*/pHT304*msrAB* cells. WT (blue), Δ*msrAB* (red), and Δ*msrAB*/pHT304msrAB (green) were grown in MOD medium as described in Figure [2](#F2){ref-type="fig"}. The cells were harvested at EE, LE and S growth phases. The Met(O) content of the intracellular proteome **(A)** and exoproteome **(B)** was calculated as the percentage of the number of Met(O) vs. the total number of Met residues. Data are the means of triplicate measures obtained from three independent cultures at the EE, LE, and S growth phases. Significant differences between two strains are indicated with one (*p* \< 0.05) or two (*p* \< 0.01) asterisks.](fmicb-08-01342-g0005){#F5}

To identify peptides exhibiting significant differences in Met(O) content in Δ*msrAB* compared with WT, we conducted a *t*-statistical analysis. For a robust analysis, we considered a peptide as containing an oxidized Met residue when it was identified in at least two biological replicates. The lists of intra- and extracellular peptides showing significant Met(O) level changes (log~2~ fold-change \> 1 and *p* ≤ 0.01) according to growth phase are presented in Tables [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}.

###### 

Cellular peptides with significant Met(O) level changes (\|log~2~\|fold-change\>1, *p* \< 0.01) in Δ*msrAB* compared with WT.

                                                **Gene no**        **NP no**   **Protein name**   **Description**                                     **Peptide name**   **Met(O) petide detected by GC-MS/MS**                             **log**~**2**~**fold-change**           
  --------------------------------------------- ------------------ ----------- ------------------ --------------------------------------------------- ------------------ ------------------------------------------------------------------ ------------------------------- ------- -------
  Glycolysis                                    [BC3971](BC3971)   NP_833690   PdhC               Alpha-keto acid dehydrogenas,e subunit E2           PdhC_2             HTAPHVTL$\text{M}$DEVDVTELVAHR                                                                     −2.32   
  Amino sugar and nucleotide sugar metabolism   [BC5288](BC5288)   NP_834951   MurA               UDP-N-acetylglucosamine 1-carboxyvinyltransferase   MurA_1             ASVQV$\text{M}$GPLLAR                                              2.38                                    
  Amino acid metabolism                         [BC1238](BC1238)   NP_831022   TrpA               Tryptophan synthase, subunit α                      TrpA_4             EVQMPFVL$\text{M}$TYLNPVLAFGK                                                                      −1.69   
                                                [BC1237](BC1237)   NP_831021   TrpB               Tryptophan synthase, subunit β                      TrpB_1             ETPLYYAEN$\text{M}$TK                                                                              −1.57   
                                                [BC1232](BC1232)   NP_831016   TrpE               Anthranilate synthase component I                   TrpE_2             A$\text{M}$EIINELENEKR                                                                             −1.02   
  Transcriptional regulators                    [BC0102](BC0102)   NP_829983   ClpC               Negative regulator of genetic competence            ClpC_6             VIELS$\text{M}$DEAR                                                −3.29                                   
                                                                                                                                                      ClpC_8             VMTLD$\text{M}$GTVVAGTK                                            −1.99                                   
                                                                                                                                                      ClpC_9             VMTLD$\text{M}$GTVVAGTK                                            −2.40                                   
                                                [BC0613](BC0613)   NP_830430   ArsR1              ArsR family transcriptional regulator               ArsR1_1            ISEEDVQ$\text{M}$LR                                                                                        1.51
  Stress response                               [BC5044](BC5044)   NP_834714   Dp2                Non-specific DNA-binding protein                    Dps2_12            KG$\text{M}$EIAQDSDDEMTSDLLLGIYTELEKHAWMLR                                                                 −1.86
                                                                   NP_834714                                                                          Dps2_9             GMEIAQDSDDEMTSDLLLGIYTELEKHAW$\text{M}$LR                                                                  −2.20
                                                [BC0377](BC0377)   NP_830216   AhpC               Alkyl hydroperoxide reductase C22                   AhpC_3             IEYI$\text{M}$IGDPTR                                               −2.34                                   
                                                [BC0376](BC0376)   NP_830215   AhpF               Alkyl hydroperoxide reductase subunit F             AhpF_18            VSAGDDNVSKD$\text{M}$LALVDELAT$\text{M}$SSK                                                                1.14
                                                [BC1155](BC1155)   NP_830941   KatE               Catalase                                            KatE_5             $\text{M}$NPNNRLTTNQGAPVGDNQNSRTAGR                                                                2.00    
  Chaperone                                     [BC0295](BC0295)   NP_830146   GroEL              Chaperone                                           GroEL_23           SALQNAASVAAMFLTTEAVVADKPEPNAPAMPD$\text{M}$GG$\text{M}$GMGGMGGMM                                           −1.67
                                                                                                                                                      GroEL_30           SALQNAASVAAMFLTTEAVVADKPEPNAPAMPDMGGMG$\text{M}$GG$\text{M}$GGMM                                           −1.51
                                                [BC1043](BC1043)   NP_830829   PrsA1              Peptidylprolyl isomerase                            PrsA1_6            QVLNN$\text{M}$VMEK                                                                                −1.59   
  Riboflavin metabolism                         [BC4112](BC4112)   NP_833830   RibH               Riboflavin synthase, subunit β                      **RibH_1**         **AGNKGYESAVAAIE$\text{M}$AHLSK**                                                                          2.88
                                                                                                                                                      RibH_3             AGTKAGNKGYESAVAAIE$\text{M}$AHLSK                                                                  1.98    2.36
                                                                                                                                                      **RibH_4**         **GVASLSLQ$\text{M}$DIPVIFGVLTTETIEQAIER**                                                                 2.75
                                                                                                                                                      RibH_5             GYESAVAAIE$\text{M}$AHLSK                                                                                  2.21
                                                                                                                                                      RibH_8             $\text{M}$ASSGKYDAVITLGTVIR                                                                                1.93
                                                                                                                                                      RibH_9             $\text{M}$VFEGHLVGTGLK                                                                                     1.92
                                                [BC4110](BC4110)   NP_833828   RibE               Riboflavin synthase, subunit α                      RibE_2             VGS$\text{M}$TESFLQENGFL                                                                                   1.32
  Ribosome components                           [BC0146](BC0146)   NP_830026   RplF               50S ribosomal protein L6                            RplF_1             ALIGN$\text{M}$VEGVTEGFAR                                                                                  −1.81
                                                [BC3825](BC3825)   NP_833546   RpsB               30S ribosomal protein S2                            RpsB_1             AG$\text{M}$YFVNQR                                                                                 −2.93   
                                                [BC0135](BC0135)   NP_830015   RpsS               SSU ribosomal protein S19P                          RpsS_4             KHVPVYITED$\text{M}$VGHK                                                                           2.20    
  Translation apparatus                         [BC0129](BC0129)   NP_830009   Tuf                Elongation factor                                   Tuf_1              ETDKPFL$\text{M}$PVEDVFSITGR                                                                       −1.90   
                                                                                                                                                      Tuf_21             TTDVTGIIQLPEGTEMVMPGDNIE$\text{M}$TIELIAPIAIEEGTK                                                  −1.76   
                                                                                                                                                      Tuf_30             VGDVVEIIGLAEENASTTVTGVE$\text{M}$FRK                                                                       1.57
                                                                                                                                                      Tuf_5              IIELMAEVDAYIPTPERETDKPFL$\text{M}$PVEDVFSITGR                                                      −2.95   
  Degradative enzyme                            [BC1991](BC1991)   NP_831760   TgC                Murein endopeptidase                                TgC_2              NI$\text{M}$DQLYGEFNK                                                                                      −1.94
  Motility                                      [BC1654](BC1654)   NP_831431   CheV               Chemotaxis protein                                  CheV_3             VIYIAEDSA$\text{M}$LR                                              1.75                                    
  Uncategorized                                 [BC1225](BC1225)   NP_831009   --                 Unknown                                             BC1225_1           $\text{M}$KLGIVIFPSK                                                                                       1.70
                                                [BC4045](BC4045)   NP_833763   --                 NAD(P)H nitroreductase                              BC4045             $\text{M}$SVEQVSEWAK                                                                                       1.14
                                                [BC4182](BC4182)   NP_833896   Gls24              Unknown                                             Gls24_3            AEHMLDMGQDTTLGKVEIAPEVIEVIAGIAAAEVEGVAA$\text{M}$R                                                 −1.02   

*Peptides with Met(O)levels restored in ΔmsrAB/pHT304-msrAB are indicated in bold. Met residues that are differentially oxidized are indicated in red. EE, early exponential growth phase; LE, late exponential growth phase; S, stationary growth phase. NA, Not annotated. Green and red highlights indicate increased and decreased protein levels, respectively*.

###### 

Exopeptides with significant Met(O) level changes (\|log~2~\|fold-change \> 1, *p* \< 0.01) in Δ*msrAB* compared with WT.

  **Functional class**                    **Gene no**        **NP no**    **Protein name**   **Description**                                      **Peptide name**   **Met(O) petide detected by GC-MS/MS**                   **log**~**2**~**fold-change**           
  --------------------------------------- ------------------ ------------ ------------------ ---------------------------------------------------- ------------------ -------------------------------------------------------- ------------------------------- ------- -------
  Carbohydrate metabolism                 [BC5135](BC5135)   NP_834803    Eno                Enolase                                              Eno_2              LGANAILGVS$\text{M}$AVAHAAADFVGLPLYR                     −2.83                           −2.67   −2.73
  Amino acid metabolism                   [BC0344](BC0344)   NP_830183    RocA               *1*-pyrroline-5-carboxylate dehydrogenase            RocA_4             F$\text{M}$EVLEEAGLPAGVVNFVPGNGSEVGDYLVDHPR              −2.02                                   
  Translation                             [BC0119](BC0119)   NP_830000    RplJ               Ribosomal protein L10                                **RplJ**           EGLLS$\text{M}$LLSVLQAPIR                                −2.21                                   
  Cell wall and cell surface metabolism   [BC5234](BC5234)   NP_834897    CwlC               N-acetylmuramoyl-L-alanine amidase                   CwlC_1             SGPSH$\text{M}$GIYLGGGSFIQAGDK                                                                   2.44
                                          [BC0679](BC0679)   NP_830492    Smc                Cell wall protein                                    Smc_3              $\text{M}$NAVSTILEADKEILR                                2.35                                    
                                                                                                                                                  Smc_1              GYNLTANPG$\text{M}$K                                     1.80                                    
  Enterotoxins                            [BC5239](BC5239)   NP_834902    EntA               Enterotoxin A                                        **EntA_2**         **VLTA$\text{M}$GHDLTANPNMK**                                                            −1.74   
                                                                                                                                                  **EntA_1**         **VLTAMGHDLTANPN$\text{M}$K**                                                                    −2.47
                                                                                                                                                  EntA_3             VLTA$\text{M}$GHDLTANPN$\text{M}$K                                                               1.87
                                          [BC0813](BC0813)   NP_830603    EntC               Enterotoxin C                                        **EntC_1**         **GNKIDVL$\text{M}$PDK**                                 2.32                                    
                                                                                                                                                  **EntC_3**         **IDVL$\text{M}$PDK**                                                                    1.65    
                                          [BC3716](BC3716)   NA           EntD               Enterotoxin D                                        **EntD_1**         **VLTA$\text{M}$GHDLTANPN$\text{M}$K**                                                   1.77    
                                          [BC3102](BC3102)   NP_832845    HblB               HBL, component B                                     **HblB_6**         **S$\text{M}$NAYSY$\text{M}$LIK**                                                        2.39    
                                                                                                                                                  **HblB_2**         **QLESDGFNV$\text{M}$K**                                                                         2.21
                                          [BC3104](BC3104)   NP_832847    HblL2              Hbl, component L1                                    **HblL2_7**        **LIQTYIDQSL$\text{M}$SPNVQLEEVTALNTNQFLIK**             −3.10                           −1.87   −2.18
                                                                                                                                                  **HblL2_9**        **S$\text{M}$LLLTQNDLHTFANQIDVELDLLK**                   −2.21                                   
                                                                                                                                                  **HblL2_10**       **S$\text{M}$LLLTQNDLHTFANQIDVELDLLKR**                  −2.49                                   −1.93
                                                                                                                                                  **HblL2_12**       **TQEYDL$\text{M}$KVIDTEK**                                                              1.96    
                                                                                                                                                  **HblL2_8**        **QD$\text{M}$KEWSSELYPQLILLNSK**                                                                2.09
                                          [BC3523](BC3523)   NP_833256    HlyII              Hemolysin II                                         HlyII_1            ALEEQ$\text{M}$NSINSVNDKLNK                              −2.21                                   
                                          [BC1809](BC1809)   NP_831582    NheA               Nhe component A                                      **NheA_2**         **LIDLNQE$\text{MM}$R**                                                                  2.21    
                                          [BC1810](BC1810)   NP_831583    NheB               Nhe, component B                                     **NheB_3**         **TQTEYLTNTIDTAITALQNISNQWYT$\text{M}$GSK**              −2.21                           −2.27   −1.65
                                                                                                                                                  **NheB_2**         **TGSNALV$\text{M}$DLYALTIIK**                                                           −1.76   
  Flagella                                [BC1657](BC1657)   NP_831434    FlaA               Flagellin                                            **FlaA_9**         **LDHNLNNVTSQATN$\text{M}$ASAASQIEDADMAK**               −2.21                           −1.67   
                                                                                                                                                  **FlaA_6**         **ILNEAGIS$\text{M}$LSQANQTPQMVSK**                                                      2.92    
                                                                                                                                                  FlaA_5             ILNEAGISMLSQANQTPQ$\text{M}$VSK                                                          2.19    
                                                                                                                                                  **FlaA_4**         **ILNEAGIS$\text{M}$LSQANQTPQMVSK**                                                      1.78    
                                                                                                                                                  FlaA_20            $\text{M}$RINTNINSMR                                                                             −1.78
                                          [BC1658](BC1658)   NP_831435    FlaB               Flagellin                                            FlaB_7             ILNEAGISMLSQANQTPQ$\text{M}$VSK                                                          −2.77   
                                                                                                                                                  FlaB_8             ILNEAGIS$\text{M}$LSQANQTPQMVSK                                                          −2.77   
                                                                                                                                                  FlaB_9             ILNEAGIS$\text{M}$LSQANQTPQ$\text{M}$VSK                                                 −2.77   
                                                                                                                                                  FlaB_14            LDHNLNNVTSQATNMAAAASQIEDADMAKE$\text{M}$SE$\text{M}$TK                                   −2.29   
                                                                                                                                                  FlaB_11            LDHNLNNVTSQATNMAAAASQIEDAD$\text{M}$AK                                                   −2.03   
                                                                                                                                                  FlaB_15            LDHNLNNVTSQATN$\text{M}$AAAASQIEDADMAKEMSEMTK                                            −1.67   
                                                                                                                                                  FlaB_12            LDHNLNNVTSQATN$\text{M}$AAAASQIEDADMAK                                                   −1.34   
                                                                                                                                                  FlaB_26            TNFNGNSFLDTTATPPGKDIEIQLSDASGDT$\text{M}$TLK                                             −1.52   −2.06
  Degradative enzymes                     [BC2735](BC2735)   NP_832488.   NprP2              Bacillolysin                                         NprP2_3            FEAATPNYVSGTYLVNAQNGD$\text{M}$LK                                                        −1.61   
                                          [BC3761](BC3761)   NP_833485    PlcA               1-phosphatidylinositol phosphodiesterase precursor   **PlcA_4**         **W$\text{M}$QPIPDNIPLAR**                                                               2.39    
                                          [BC1991](BC1991)   NP_831760    TgC                Putative murein endopeptidase                        **TgC_3**          **NI$\text{M}$DQLYGEFNKIVDADEYVK**                                                       −2.09   
                                                                                                                                                  TgC_10             YKQS$\text{M}$DGTMQDIKK                                                                  −2.31   
                                                                                                                                                  **TgC_2**          **NI$\text{M}$DQLYGEFNK**                                                                1.15    
                                          [BC5135](BC5135)   NP_834895    YvgJ2              phosphoglycerol transferase                          **YvgJ2_2**        **DIEYFDQSIDMLK**                                        2.18                                    
  Uncategorized                           [BC2077](BC2077)   NP_831845    BC2077             ESAT-6-like protein                                  BC2077             VQNFAQLLQEIN$\text{M}$QLNK                                                                       −2.47
                                          [BC1894](BC1894)   NP_831667    BC1894             Phage protein                                        BC1894_1           QDTAAGYQILSFVSDLPGGAISSVVVDLN$\text{M}$PK                                                        −2.18

*Exopeptides with Met(O) levels restored in ΔmsrAB/pHT304msrAB are indicated in bold. Met residues that are differentially oxidized are indicated in red. EE, early exponential growth phase; LE, late exponential growth phase; S, stationary growth phase. NA, Not annotated. Green and red highlights indicate increased and decreased protein levels, respectively*.

### Cellular proteome

The number of peptides with Met(O) content changes was lower at the EE (6) than the LE (13) and S (19) growth phases. Only one peptide, a RibH-related peptide, showed similar changes in the two growth phases (Table [3](#T3){ref-type="table"}). At the EE growth phase, we noted that the subunit E2 of the pyruvate dehydrogenase complex (PdhC), which interconnects glycolysis with acetate metabolism, had one peptide with a decreased Met(O) level in EE phase. This could impact the activity of this enzyme and contribute to the metabolic perturbation observed in Δ*msrAB* at EE phase (Figure [2](#F2){ref-type="fig"}; Martin et al., [@B40]). At the LE growth phase, the majority of the identified peptides showed a lower Met(O) content in Δ*msrAB* compared with WT at LE phase. This is consistent with the results presented in Figure [4](#F4){ref-type="fig"}. At the S growth phase, the majority of the identified peptides (12/18) showed a higher Met(O) level in Δ*msrAB* compared with WT. Among these 12 peptides, 6 are RibH-related peptides. Two of these six peptides had their Met(O) level restored in Δ*msrAB*/pHT304*msrAB* (Table [3](#T3){ref-type="table"}). RibH contains four Met residues: all of these were more highly oxidized in Δ*msrAB* than in WT at the S growth phase and two were more highly oxidized in Δ*msrAB* than in Δ*msrAB*/pHT304*msrAB*. RibH is thus a target of MsrAB activity and the major contributor to the difference observed between Δ*msrAB* and WT on the one hand, and Δ*msrAB* and Δ*msrAB*/pHT304*msrAB* on the other, at the S growth phase (Figure [5](#F5){ref-type="fig"}).

### Exoproteome

Table [4](#T4){ref-type="table"} shows that peptides with differential Met(O) contents belong to 21 proteins, including eight toxin-related proteins. The LE growth phase sustained the highest number of peptides with increased Met(O) levels (10); the majority of these peptides (9/10) had their Met(O) level restored in Δ*msrAB*/pHT304*msrAB*, indicating a direct impact of MsrAB. Among the proteins with increased oxidation of Met residues were the degradative enzyme, PlcA, the flagellin, FlaA, and the four toxin-related proteins, NheA, HblB, EntC and EntD. Only PlcA and HblB showed increased abundance levels at LE growth phase (Table [2](#T2){ref-type="table"}). FlaB was the protein for which we detected the largest number of Met(O) peptides and Met residues with differential oxidation (7 Met residues). All of these residues were less oxidized in Δ*msrAB* compared with WT at LE phase. In addition, we observed that FlaB was less abundant in Δ*msrAB* at LE phase (Table [2](#T2){ref-type="table"}). The loss of Met-oxidized peptides could thus be due to degradation of protein copies. This is possibly also the case for HlyII (Tables [2](#T2){ref-type="table"}, [4](#T4){ref-type="table"}). In S growth phase, the peptides with increased Met(O) content belong to the putative N-acetylmuramoyl-L-alanine amidase CwlC and the toxin-related EntA, HblB, and HblL2. All HblL2-bound Met were not equally susceptible to *msrAB* disruption, as one Met residue was more oxidized at the S growth phase, one was more oxidized at the LE growth phase and two were less oxidized, especially at the EE growth phase. Taken together, the results indicate that MsrAB regulates the dynamic of the Met(O) level of the exoproteome by controlling the Met(O) level of target peptides in a growth phase- and protein-dependent manner. Importantly, our results indicate that virulence factors such enterotoxins, degradative enzymes, and flagella components are MsrAB targets.

Discussion {#s4}
==========

Methionine (Met) residues in proteins and their recycling by methionine sulfoxide reductases (Msrs) are part of the antioxidant system produced by aerobic microorganisms. The antioxidant system keeps a steady-state control over ROS production-detoxification (Levine et al., [@B34]; Kim, [@B29]). The tight regulation of ROS production and detoxification represents the basis for the maintenance of an appropriate redox homeostasis, which is central for growth.

While Met residues in cellular proteins are well-recognized as antioxidants, the relative importance of Met residues in extracellular proteins has hitherto not been established. In this study, we used next-generation proteomics on wild-type *B. cereus* and an MsrAB mutant to demonstrate that Met residues in exoproteins could be reversibly oxidized to Met(O), probably before their exportation. In addition, we provide the first evidence that *B. cereus* can modulate its capacity and specificity for protein export (secretion) through the growth phase-dependent expression of the methionine sulfoxide reductase-encoding gene, *msrAB*.

As reported for other *msr* genes in several bacteria, *msrAB* expression is lower in exponentially grown *B. cereus* cells than in growth-arrested cells. The low level of *msrAB* expression is probably sufficient to maintain a proper activity of the antioxidant system during exponential growth phase. The increased expression of *msrAB* at the end of growth would serve to minimize the accumulation of oxidative damage on ROS-affected molecules (Dukan and Nystrom, [@B18]). However, the expression level of *msrAB* in *B. cereus* cells is not by itself sufficient to prevent premature growth arrest under full aerobic conditions as growth can be prolonged by overproducing *msrAB*. In WT cells, premature growth arrest allows the cells to survive for extended time periods, suggesting that MsrAB could be a regulator of normal lifespan of *B. cereus* (Koc et al., [@B30]).

Considering the primary antioxidant function of MsrAB, variation of other antioxidant proteins was expected in MsrAB-deficient cells as a part of putative compensatory mechanisms or due to altered interactions with MsrAB (Alamuri and Maier, [@B3]). We observed abundance level changes in antioxidant proteins, mainly at LE phase, due to the lack of protection normally conferred by the high expression of *msrAB*. Neutralizing ROS without quelling its production may prove to be onerous to *B. cereus*. Our results indicate that *B. cereus* reprograms its proteome to both counteract and inhibit the formation of ROS in *msrAB*-deficient cells. This proteome modification leads to novel metabolic networks that allow the alleviation of TCA cycle activity, the main metabolic network that supplies NADH for oxidative phosphorylation. When the machinery involved in oxidative phosphorylation is severely impeded by the ROS challenge, glucose uptake is enhanced to satisfy the ATP need by substrate level phosphorylation. Increased carbon flow also maintains constant levels of glycolytic intermediates as macromolecular precursors and boosts carbon flow through the PPP, which produces large amount of NADPH, a key molecule that is used to drive anabolic processes and provides the reducing power to the antioxidative system. PPP is also required for synthesis of the low-molecular-weight bacillithiol (Richardson et al., [@B46]).

When *msrAB* is disrupted, *B. cereus* accumulates a higher level of Met(O) exoproteins in the growth medium and a lower level of Met(O) cellular protein at LE phase. This suggests that *B. cereus* can overcome the lack of MsrAB activity by promoting export of Met(O) proteins to maintain intracellular redox homeostasis. Our results indicate that MsrAB deficiency promotes export of some proteins by directly or indirectly modulating the efficiency of the translocation/secretion machinery. Among these proteins are proteases, which probably contribute to the high proteolytic activity of the growth medium of *msrAB*-deficient cells and the highly reduced exoprotein level at the end of growth (Figure [3](#F3){ref-type="fig"}). Upregulation of proteases has been reported in several bacteria as part of the secretion stress response, which is induced to prevent the accumulation of misfolded proteins outside the cytoplasmic membrane (Westers et al., [@B62]). MsrAB deficiency leads to the accumulation of oxidized proteins, and oxidation can induce protein misfolding (Tarrago et al., [@B56]). Thus, MsrAB deficiency may trigger a secretion stress response likely to degrade the misfolded proteins, which could interfere with the correct functionality of the cell (Sarvas et al., [@B52]). In conclusion, *msrAB* expression may prevent extracellular accumulation of faulty proteins to avoid negative effects in the exported/secreted proteins.

We have shown previously that Met residues in toxin-related proteins may act as ROS scavengers before being secreted (Madeira et al., [@B36]), and we report here that Met(O) in toxin-related proteins are MsrAB substrates. This indicates that Met residues in toxin-related proteins contribute to the endogenous antioxidant system (Levine et al., [@B34], [@B33]; Luo and Levine, [@B35]; Kim, [@B29]), and thus to the cellular redox homeostasis of *B. cereus* (Duport et al., [@B20]). The reversible oxidation of Met to Met(O) has been suggested to be a mechanism for modulating protein activity (Kanayama et al., [@B27]). Therefore, catalyzed reduction of Met(O) in toxin-related proteins could be an antioxidant mechanism and a protein regulatory mechanism. This raises important questions about the role of this modification in the biological activity of toxins, and thus in the cytotoxicity of *B. cereus* according to growth phase.
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